Kiniksa Pharmaceuticals International Insider Trades
NASDAQ: KNSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 19 · $36.40M
- Shares bought / sold
- 0 / 698.30K
- Net activity
- Net selling $36.4 million
Kiniksa Pharmaceuticals International insider activity
Over the last 12 months, Kiniksa Pharmaceuticals International insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 19 sales. Insiders bought $0 and sold $36.4 million worth of stock, for net insider selling of $36.4 million. The largest seller was Patel Sanj K, with $29.4 million in reported sales.
The most recent filing shows Megna Michael R (CHIEF ACCOUNTING OFFICER) selling 4,600 shares at $80.30 on Sep 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KNSA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
KNSA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 3, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Sale | 4,600 | $369.38K | Form 4 |
| Sep 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Tax withholding | 5,531 | $438.50K | Form 4 |
| Sep 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Option exercise | 2,644 | — | Form 4 |
| Sep 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Option exercise | 2,362 | — | Form 4 |
| Sep 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Option exercise | 2,558 | — | Form 4 |
| Sep 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Option exercise | 3,932 | — | Form 4 |
| Sep 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Tax withholding | 4,029 | $319.42K | Form 4 |
| Sep 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 2,457 | — | Form 4 |
| Sep 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 1,750 | — | Form 4 |
| Sep 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 1,624 | — | Form 4 |
| Sep 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 2,497 | — | Form 4 |
| Sep 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Tax withholding | 4,007 | $317.67K | Form 4 |
| Sep 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Option exercise | 2,457 | — | Form 4 |
| Sep 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Option exercise | 1,740 | — | Form 4 |
| Sep 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Option exercise | 1,611 | — | Form 4 |
| Sep 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Option exercise | 2,477 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Tax withholding | 15,144 | $1.20M | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 8,609 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 6,237 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 6,481 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 9,991 | — | Form 4 |
| Sep 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Tax withholding | 4,404 | $349.15K | Form 4 |
| Sep 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 3,069 | — | Form 4 |
| Sep 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 1,591 | — | Form 4 |
| Sep 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 1,750 | — | Form 4 |
| Sep 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 2,694 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Tax withholding | 15,144 | $1.20M | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 8,609 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 6,237 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 6,481 | — | Form 4 |
| Sep 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 9,991 | — | Form 4 |
| Aug 19, 2026 | Quart Barry DDirector | Gift | 2,600 | — | Form 4 |
| Aug 1, 2026 | Levy Richard SDirector | Option exercise | 403 | — | Form 4 |
| Jul 29, 2026 | Cole G BradleyDirector | Gift | 4,500 | — | Form 4 |
| Jul 29, 2026 | Cole G BradleyDirector | Sale | 3,673 | $299.09K | Form 4 |
| Jul 15, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Award | 279 | $9.35K | Form 4 |
| Jun 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Conversion | 900,000 | — | Form 4 |
| May 29, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 6,078 | — | Form 4 |
| May 29, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 6,078 | — | Form 4 |
| May 29, 2026 | McCain Tracey LDirector | Option exercise | 2,799 | — | Form 4 |
| May 29, 2026 | Quart Barry DDirector | Option exercise | 2,799 | — | Form 4 |
| May 29, 2026 | Cole G BradleyDirector | Option exercise | 2,799 | — | Form 4 |
| May 29, 2026 | Levy Richard SDirector | Option exercise | 2,799 | — | Form 4 |
| May 29, 2026 | Malley ThomasDirector | Option exercise | 2,799 | — | Form 4 |
| May 29, 2026 | Popovits Kimberly JDirector | Option exercise | 2,799 | — | Form 4 |
| May 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 48,565 | $2.62M | Form 4 |
| May 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 48,565 | $1.50M | Form 4 |
| May 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sale | 21,097 | $1.14M | Form 4 |
| May 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sale | 37,327 | $2.00M | Form 4 |
| May 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 58,424 | $605.27K | Form 4 |
| Apr 30, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 2,141 | $115.64K | Form 4 |
| Apr 30, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 2,141 | $66.22K | Form 4 |
| Apr 29, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 22,544 | $1.22M | Form 4 |
| Apr 29, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 22,544 | $697.29K | Form 4 |
| Apr 28, 2026 | Quart Barry DDirector | Sale | 13,099 | $656.26K | Form 4 |
| Apr 28, 2026 | Quart Barry DDirector | Option exercise | 13,099 | $187.71K | Form 4 |
| Apr 28, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 51,750 | $2.80M | Form 4 |
| Apr 28, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 243,596 | $12.67M | Form 4 |
| Apr 28, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 113,673 | $5.85M | Form 4 |
| Apr 28, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 74,635 | $3.76M | Form 4 |
| Apr 28, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 51,750 | $1.60M | Form 4 |
| Apr 28, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 431,904 | $4.47M | Form 4 |
| Apr 9, 2026 | Moat RossCHIEF OPERATING OFFICER | Sale | 1,703 | $79.51K | Form 4 |
| Apr 9, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Sale | 6,625 | $309.32K | Form 4 |
| Apr 7, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Tax withholding | 1,666 | $81.53K | Form 4 |
| Apr 7, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Option exercise | 3,932 | $3.93K | Form 4 |
| Apr 7, 2026 | Moat RossCHIEF OPERATING OFFICER | Tax withholding | 774 | $37.88K | Form 4 |
| Apr 7, 2026 | Moat RossCHIEF OPERATING OFFICER | Option exercise | 2,477 | — | Form 4 |
| Apr 7, 2026 | Tessari EbenCHIEF STRATEGY OFFICER | Tax withholding | 846 | $41.40K | Form 4 |
| Apr 7, 2026 | Tessari EbenCHIEF STRATEGY OFFICER | Option exercise | 2,726 | — | Form 4 |
| Apr 7, 2026 | Patel Sanj KCHAIRMAN & CEO | Tax withholding | 4,831 | $236.43K | Form 4 |
| Apr 7, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 9,991 | — | Form 4 |
| Apr 7, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Tax withholding | 1,208 | $59.12K | Form 4 |
| Apr 7, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 2,497 | — | Form 4 |
| Apr 7, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Tax withholding | 1,303 | $63.77K | Form 4 |
| Apr 7, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 2,694 | — | Form 4 |
| Apr 6, 2026 | Moat RossCHIEF OPERATING OFFICER | Sale | 2,367 | $114.99K | Form 4 |
| Apr 6, 2026 | Quart Barry DDirector | Sale | 6,901 | $345.05K | Form 4 |
| Apr 6, 2026 | Quart Barry DDirector | Option exercise | 6,901 | $98.89K | Form 4 |
| Apr 6, 2026 | Patel Sanj KCHAIRMAN & CEO | Sale | 7,278 | $363.97K | Form 4 |
| Apr 6, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 7,278 | $75.40K | Form 4 |
| Apr 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Tax withholding | 3,205 | $154.26K | Form 4 |
| Apr 1, 2026 | Megna Michael RCHIEF ACCOUNTING OFFICER | Option exercise | 7,564 | — | Form 4 |
| Apr 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Tax withholding | 10,313 | $496.36K | Form 4 |
| Apr 1, 2026 | Patel Sanj KCHAIRMAN & CEO | Option exercise | 21,327 | — | Form 4 |
| Apr 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Tax withholding | 2,510 | $120.81K | Form 4 |
| Apr 1, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 5,187 | — | Form 4 |
| Apr 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Tax withholding | 1,706 | $82.11K | Form 4 |
| Apr 1, 2026 | Moat RossCHIEF OPERATING OFFICER | Option exercise | 5,808 | — | Form 4 |
| Apr 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Tax withholding | 2,821 | $135.77K | Form 4 |
| Apr 1, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 5,831 | — | Form 4 |
| Apr 1, 2026 | Tessari EbenCHIEF STRATEGY OFFICER | Tax withholding | 1,756 | $84.52K | Form 4 |
| Apr 1, 2026 | Tessari EbenCHIEF STRATEGY OFFICER | Option exercise | 5,975 | — | Form 4 |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sale | 18,741 | $866.58K | Form 4 |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sale | 17,981 | $819.57K | Form 4 |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 10,360 | $277.03K | Form 4 |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 13,813 | $249.46K | Form 4 |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 10,513 | $186.71K | Form 4 |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | 2,036 | $46.60K | Form 4 |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Option exercise | 40,000 | $414.40K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4